Conference Proceedings

ALINA: A phase III study of alectinib versus chemotherapy as adjuvant therapy in patients with stage IB IIIA anaplastic lymphoma kinase-positive (ALK plus ) non-small cell lung cancer (NSCLC).

Benjamin J Solomon, Jin Seok Ahn, Fabrice Barlesi, Rafal Dziadziuszko, Makoto Nishio, Alice Tsang Shaw, Walter Bordogna, Christoph Meyenberg, Yi-Long Wu

Pneumologie | AMER SOC CLINICAL ONCOLOGY | Published : 2019